Moderna trains its mRNA tech on the common cold and a triple whammy against 3 respiratory diseases

Moderna is adding another two vaccine programs to its roster: a combination respiratory candidate and a shot targeting all four endemic human coronaviruses that cause the common cold.

The respiratory combo candidate will go after the three most significant viruses that cause respiratory diseases in adults: SARS-CoV-2, influenza and respiratory syncytial virus (RSV). Moderna has dubbed this triple shot mRNA-1230, and it's designed to be used as an annual booster, according to a Tuesday press release.